# Inovio Pharmaceuticals, Inc.: filings

INO · Nasdaq · CIK 1055726 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ino.md) · [Financials](/companies/ino/financials.md) · [Filings](/companies/ino/filings.md) · [Insiders](/companies/ino/insiders.md)

## Reports and events: 246 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 459, 8-K 150, 10-Q 53, 424B5 37, 3 24, SC 13G/A 23, DEF 14A 19, S-8 19, 10-K 18, UPLOAD 15, EFFECT 14, SCHEDULE 13G/A 14, SC 13G 12, CORRESP 11, S-3 11, SCHEDULE 13G 9, CT ORDER 6, 425 5, 424B3 4, 8-K/A 4, ARS 4, PRE 14A 4, S-3/A 4, 4/A 3, DEFA14A 3, S-4/A 3, 424B2 2, D 2, POS AM 2, SC 13D 2, 144 1, 25 1, 3/A 1, 5 1, 8-A12B 1, CERTNAS 1, DEL AM 1, NT 10-Q 1, POSASR 1, POS EX 1, S-3ASR 1, S-8 POS 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-06 | 20:06 ET | [8-K](/filings/0001193125-26-415555.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-415555 |
| 2026-08-12 | 20:07 ET | [8-K](/filings/0001055726-26-000024.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001055726-26-000024 |
| 2026-08-12 | 20:00 ET | [10-Q](/filings/0001055726-26-000023.md) | Quarterly report, period 2026-06-30 | 0001055726-26-000023 |
| 2026-07-31 | 11:23 ET | [8-K](/filings/0001193125-26-326785.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-326785 |
| 2026-07-29 | 20:03 ET | [8-K](/filings/0001193125-26-323628.md) | 2.02 Results of operations | 0001193125-26-323628 |
| 2026-05-20 | 20:01 ET | [8-K](/filings/0001193125-26-232524.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-232524 |
| 2026-05-13 | 20:07 ET | [8-K](/filings/0001055726-26-000019.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001055726-26-000019 |
| 2026-05-13 | 20:01 ET | [10-Q](/filings/0001055726-26-000018.md) | Quarterly report, period 2026-03-31 | 0001055726-26-000018 |
| 2026-04-07 | 20:11 ET | [DEF 14A](/filings/0001055726-26-000011.md) | Proxy statement, period 2026-05-20 | 0001055726-26-000011 |
| 2026-04-06 | 11:03 ET | [8-K](/filings/0001193125-26-142885.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-142885 |
| 2026-04-02 | 10:15 ET | [8-K](/filings/0001193125-26-138870.md) | 8.01 Other events | 0001193125-26-138870 |
| 2026-03-12 | 20:07 ET | [8-K](/filings/0001055726-26-000009.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001055726-26-000009 |
| 2026-03-12 | 20:01 ET | [10-K](/filings/0001055726-26-000008.md) | Annual report, period 2025-12-31 | 0001055726-26-000008 |
| 2026-01-27 | 21:12 ET | [8-K](/filings/0001193125-26-024431.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001193125-26-024431 |
| 2025-12-29 | 13:20 ET | [8-K](/filings/0001193125-25-332322.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-332322 |
| 2025-11-12 | 11:16 ET | [8-K](/filings/0001193125-25-275721.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-275721 |
| 2025-11-10 | 21:08 ET | [8-K](/filings/0001055726-25-000064.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001055726-25-000064 |
| 2025-11-10 | 21:01 ET | [10-Q](/filings/0001055726-25-000063.md) | Quarterly report, period 2025-09-30 | 0001055726-25-000063 |
| 2025-08-12 | 20:08 ET | [8-K](/filings/0001055726-25-000056.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001055726-25-000056 |
| 2025-08-12 | 20:01 ET | [10-Q](/filings/0001055726-25-000055.md) | Quarterly report, period 2025-06-30 | 0001055726-25-000055 |
| 2025-07-07 | 11:30 ET | [8-K](/filings/0001193125-25-155830.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-155830 |
| 2025-05-22 | 21:15 ET | [8-K](/filings/0001055726-25-000045.md) | 5.07 Shareholder vote results | 0001055726-25-000045 |
| 2025-05-13 | 20:08 ET | [8-K](/filings/0001055726-25-000027.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001055726-25-000027 |
| 2025-05-13 | 20:00 ET | [10-Q](/filings/0001055726-25-000026.md) | Quarterly report, period 2025-03-31 | 0001055726-25-000026 |
| 2025-04-07 | 20:08 ET | [DEF 14A](/filings/0001055726-25-000018.md) | Proxy statement, period 2025-05-20 | 0001055726-25-000018 |
| 2025-03-18 | 20:08 ET | [8-K](/filings/0001055726-25-000013.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001055726-25-000013 |
| 2025-03-18 | 20:00 ET | [10-K](/filings/0001055726-25-000012.md) | Annual report, period 2024-12-31 | 0001055726-25-000012 |
| 2024-12-16 | 13:25 ET | [8-K](/filings/0001193125-24-279061.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-279061 |
| 2024-11-14 | 21:07 ET | [8-K](/filings/0001055726-24-000053.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001055726-24-000053 |
| 2024-11-14 | 21:01 ET | [10-Q](/filings/0001055726-24-000052.md) | Quarterly report, period 2024-09-30 | 0001055726-24-000052 |
| 2024-08-13 | 10:06 ET | [8-K](/filings/0001193125-24-199331.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-199331 |
| 2024-08-08 | 21:00 ET | [8-K](/filings/0001193125-24-197065.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-197065 |
| 2024-08-08 | 20:00 ET | [10-Q](/filings/0001055726-24-000046.md) | Quarterly report, period 2024-06-30 | 0001055726-24-000046 |
| 2024-05-28 | 20:01 ET | [8-K](/filings/0001193125-24-148076.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-24-148076 |
| 2024-05-13 | 20:10 ET | [8-K](/filings/0001193125-24-137228.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-137228 |
| 2024-05-13 | 20:01 ET | [10-Q](/filings/0001055726-24-000020.md) | Quarterly report, period 2024-03-31 | 0001055726-24-000020 |
| 2024-04-17 | 20:04 ET | [8-K](/filings/0001193125-24-099067.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-099067 |
| 2024-04-11 | 20:10 ET | [DEF 14A](/filings/0001055726-24-000014.md) | Proxy statement, period 2023-12-31 | 0001055726-24-000014 |
| 2024-03-06 | 21:01 ET | [10-K](/filings/0001055726-24-000011.md) | Annual report, period 2023-12-31 | 0001055726-24-000011 |
| 2024-01-25 | 21:02 ET | [8-K](/filings/0001193125-24-015380.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-24-015380 |
| 2024-01-12 | 22:27 ET | [8-K](/filings/0001193125-24-007674.md) | 5.07 Shareholder vote results | 0001193125-24-007674 |
| 2023-11-28 | 21:05 ET | [DEF 14A](/filings/0001193125-23-284277.md) | Proxy statement, period 2024-01-12 | 0001193125-23-284277 |
| 2023-11-09 | 21:15 ET | [8-K](/filings/0001193125-23-274515.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-274515 |
| 2023-11-09 | 21:00 ET | [10-Q](/filings/0001055726-23-000055.md) | Quarterly report, period 2023-09-30 | 0001055726-23-000055 |
| 2023-11-02 | 20:01 ET | [8-K](/filings/0001193125-23-269347.md) | 3.01 Delisting notice | 0001193125-23-269347 |
| 2023-10-10 | 20:00 ET | [8-K](/filings/0001193125-23-253450.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-253450 |
| 2023-08-09 | 20:23 ET | [8-K](/filings/0001193125-23-207397.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-207397 |
| 2023-08-09 | 20:00 ET | [10-Q](/filings/0001055726-23-000051.md) | Quarterly report, period 2023-06-30 | 0001055726-23-000051 |
| 2023-08-01 | 01:43 ET | [8-K](/filings/0001193125-23-199683.md) | 2.05 Exit or disposal costs | 0001193125-23-199683 |
| 2023-06-23 | 20:25 ET | [8-K](/filings/0001193125-23-173847.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-173847 |

Page 1 of 5. [Older](/companies/ino/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:03 ET. No prices; not investment advice.